Intuitive Surgical, Inc. (NASDAQ:ISRG) has received an average recommendation of “Buy” from the twenty-two analysts that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seventeen have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $554.64.

Several research firms have commented on ISRG. Goldman Sachs Group boosted their target price on Intuitive Surgical from $540.00 to $630.00 and gave the stock a “buy” rating in a report on Friday, July 20th. Stifel Nicolaus boosted their target price on Intuitive Surgical from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, July 20th. Cantor Fitzgerald reissued a “buy” rating and issued a $620.00 target price (up from $510.00) on shares of Intuitive Surgical in a report on Friday, July 20th. Bank of America boosted their target price on Intuitive Surgical from $510.00 to $600.00 and gave the stock a “buy” rating in a report on Tuesday, July 17th. Finally, Citigroup boosted their target price on Intuitive Surgical from $561.00 to $592.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd.

Shares of NASDAQ ISRG traded down $7.46 during mid-day trading on Monday, hitting $532.56. 636,228 shares of the stock traded hands, compared to its average volume of 1,097,082. Intuitive Surgical has a 52 week low of $359.75 and a 52 week high of $581.12. The firm has a market capitalization of $62.32 billion, a PE ratio of 74.07, a P/E/G ratio of 3.66 and a beta of 1.02.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The company had revenue of $920.90 million for the quarter, compared to analyst estimates of $916.22 million. During the same period in the previous year, the company posted $2.77 earnings per share. The firm’s revenue was up 14.0% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical will post 9.52 EPS for the current year.

In other news, COO Salvatore Brogna sold 2,652 shares of the company’s stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $557.39, for a total transaction of $1,478,198.28. Following the transaction, the chief operating officer now directly owns 2,049 shares of the company’s stock, valued at $1,142,092.11. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Mark J. Rubash sold 150 shares of the company’s stock in a transaction on Monday, August 27th. The shares were sold at an average price of $543.66, for a total value of $81,549.00. Following the transaction, the director now directly owns 4,116 shares in the company, valued at $2,237,704.56. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 47,311 shares of company stock worth $24,144,846. Corporate insiders own 2.20% of the company’s stock.

Several large investors have recently made changes to their positions in the company. DekaBank Deutsche Girozentrale increased its position in Intuitive Surgical by 24.8% during the third quarter. DekaBank Deutsche Girozentrale now owns 71,547 shares of the medical equipment provider’s stock valued at $40,029,000 after acquiring an additional 14,226 shares during the last quarter. Bank of Hawaii increased its position in Intuitive Surgical by 13.3% during the third quarter. Bank of Hawaii now owns 1,560 shares of the medical equipment provider’s stock valued at $895,000 after acquiring an additional 183 shares during the last quarter. CIBC World Markets Inc. increased its position in Intuitive Surgical by 4.4% during the third quarter. CIBC World Markets Inc. now owns 17,354 shares of the medical equipment provider’s stock valued at $9,961,000 after acquiring an additional 731 shares during the last quarter. Rafferty Asset Management LLC increased its position in Intuitive Surgical by 2.8% during the third quarter. Rafferty Asset Management LLC now owns 3,571 shares of the medical equipment provider’s stock valued at $2,050,000 after acquiring an additional 96 shares during the last quarter. Finally, FIL Ltd purchased a new stake in Intuitive Surgical during the third quarter valued at $11,054,000. 84.16% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

See Also: What are the Benefits of Index Funds?

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.